Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply
Lancet Reg Health Eur. 2022 Mar 22:15:100344.
doi: 10.1016/j.lanepe.2022.100344.
eCollection 2022 Apr.
1 National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, P.O. Box 1, Bilthoven, 3720 BA, the Netherlands.
2 Department of Internal Medicine, Division of Infectious Diseases and Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, P.O. Box 22660, Amsterdam, 1100 DD, the Netherlands.
3 Department of Internal Medicine and Radboudumc Center for Infectious Diseases (RCI), Radboud university medical center, P.O. Box 9101, Nijmegen, 6500 HB, the Netherlands.
4 Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, P.O. Box 22660, Amsterdam, 1100 DD, the Netherlands.
5 National Institute for Public Health and the Environment (RIVM), Department for Statistics, Informatics and Modeling, P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.